html xmlns=”http://www.w3.org/1999/xhtml”>
abacavir
access (to services)
addiction
adherence (to treatment)
adjustment disorder
adjuvant therapies
Africa
African Americans
ageing
agraphia
AIDS mania, see also mania
AIDSTAR-One
ALCAM
alcohol use
alexia
Alzheimer’s disease
American Academy of Neurology (AAN)
amitriptyline
amphetamines
amprenavir
amyloid plaque formation
anhedonia
animal studies
antidepressants
antipsychotics
antiretroviral treatments (ART)
antiretroviral treatments (ART), cont.
anxiety disorders
apathy
aphasia
APOBEC
apolipoprotein E
astrocytes
asymptomatic neurocognitive impairment (ANI)
atazanavir
Australia
azidothymidine
behavioural therapies
biobehavioural methods
bipolar disorder
blood transfusion
blood-brain barrier (BBB)
brain imaging
brain microvascular endothelial cell (BMVEC) membrane
Brazil
buprenorphine
bupropion
Butabika National Referral Mental Hospital
California computerized assessment package (CAL-CAP)
Cambodia
cannabis see marijuana
Cape Town
carbamazepine (CBZ)
Caribbean
cART see antiretroviral treatments
CCR5 receptor
CD4 cell count
CD99
Centers for Disease Control (CDC)
central nervous system (CNS)
CEP-1347
cerebrospinal fluid (CSF) studies
chemokines
children
China
chlorpromazine
clozapine
CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER)
CNS penetration/effectiveness (CPE) rank
cocaine
Cochrane Library
cognitive impairment
Cognitive Intervention Trial-2 (CIT-2)
cognitive rehabilitation
cognitive tests
cognitive-behavioural therapy (CBT)
coma
combination antiretroviral therapy (cART) see antiretroviral treatments
Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE)
condom use
contingency management (CM)
Coping with HIV/AIDS in the Southeast (CHASE)
cost-saving
counselling
Cournos, Francine
CPI-1189
cytokines
darunavir
dehydroepiandrosterone
delavirdine
delirium
dementia, HIV-associated see HIV-associated dementia
demoralization
depression
desipramine
desvenlafaxine
DHPG
diazepam
didanosine
diffusion tensor imaging, (DTI)
disinhibition
distress
donor funding
drug interactions
DSM-IV
duloxetine
educational attainment
efavirenz